Cargando…

Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option

Immunotherapy is one of the promising strategies in the treatment of oncology. Immune checkpoint inhibitors, as a type of immunotherapy, have no significant efficacy in the clinical treatment of patients with pMMR/MSS/MSI-L mCRC alone. Therefore, there is an urgent need to find combination therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Yi, Miao, Jia-Meng, Wang, Yuan-Yuan, Fan, Zheng, Kong, Xian-Bin, Yang, Long, Cheng, Gong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334725/ https://www.ncbi.nlm.nih.gov/pubmed/35911673 http://dx.doi.org/10.3389/fimmu.2022.961796

Ejemplares similares

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
por: Zeng, Jiayi, et al.
Publicado: (2021)

Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
por: Wang, Ding, et al.
Publicado: (2021)

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer
por: Crupi, Mathieu J. F., et al.
Publicado: (2022)

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
por: Song, Yuxiao, et al.
Publicado: (2020)

The gamble between oncolytic virus therapy and IFN
por: Li, Qingbo, et al.
Publicado: (2022)

Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option
por: Asija, Sweety, et al.
Publicado: (2023)

Nano-Chemotherapy synergize with immune checkpoint inhibitor- A better option?
por: Qian, Xinye, et al.
Publicado: (2022)

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application
por: Huo, Jin-Ling, et al.
Publicado: (2022)

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
por: Kabacaoglu, Derya, et al.
Publicado: (2018)

Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021)

Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions
por: Chen, Jiao-Ting, et al.
Publicado: (2023)

Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
por: Shi, Tao, et al.
Publicado: (2020)

Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses
por: Jafari, Mahdie, et al.
Publicado: (2022)

Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
por: Chen, Yue, et al.
Publicado: (2022)

Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology
por: Liu, Zefan, et al.
Publicado: (2022)

Colorectal Cancer Immunotherapy: Options and Strategies
por: Johdi, Nor Adzimah, et al.
Publicado: (2020)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
por: Sun, Haoyu, et al.
Publicado: (2019)

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
por: Wurster, Sebastian, et al.
Publicado: (2022)

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
por: Hou, Aohan, et al.
Publicado: (2020)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
por: Yan, Yiyi, et al.
Publicado: (2018)

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
por: LaRocca, Christopher J., et al.
Publicado: (2018)

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer
por: Chen, Qiong-Yuan, et al.
Publicado: (2021)

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning
por: Gong, Li, et al.
Publicado: (2023)

PET/CT molecular imaging in the era of immune-checkpoint inhibitors therapy
por: Gao, Yuan, et al.
Publicado: (2022)

Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
por: Zhao, Yujie, et al.
Publicado: (2022)

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
por: Bartee, Eric, et al.
Publicado: (2017)

The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
por: Ren, Sijia, et al.
Publicado: (2021)

Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017)

A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner
por: El-Sayes, Nader, et al.
Publicado: (2022)

Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
por: Mougel, Alice, et al.
Publicado: (2019)

Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors
por: Eckert, Franziska, et al.
Publicado: (2019)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020)

Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy
por: Falade, Ayo S., et al.
Publicado: (2022)

Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis
por: Hao, Wenjing, et al.
Publicado: (2023)

Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Li, Yan, et al.
Publicado: (2021)

Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
por: Kurago, Zoya, et al.
Publicado: (2023)

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2021)

Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs
por: St-Cyr, Guillaume, et al.
Publicado: (2023)

Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade
por: Appleton, Elizabeth, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f2mn8alidgl9b99f2ebflhdmt4